HK1254670A1 - 曲普坦粉末用於肺部給藥 - Google Patents
曲普坦粉末用於肺部給藥Info
- Publication number
- HK1254670A1 HK1254670A1 HK18113651.3A HK18113651A HK1254670A1 HK 1254670 A1 HK1254670 A1 HK 1254670A1 HK 18113651 A HK18113651 A HK 18113651A HK 1254670 A1 HK1254670 A1 HK 1254670A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- triptan
- powders
- pulmonary delivery
- pulmonary
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562188338P | 2015-07-02 | 2015-07-02 | |
| PCT/US2016/040660 WO2017004501A1 (en) | 2015-07-02 | 2016-07-01 | Triptan powders for pulmonary delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1254670A1 true HK1254670A1 (zh) | 2019-07-26 |
Family
ID=57609192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18113651.3A HK1254670A1 (zh) | 2015-07-02 | 2018-10-24 | 曲普坦粉末用於肺部給藥 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10034857B2 (zh) |
| EP (1) | EP3316865A4 (zh) |
| JP (1) | JP2018524346A (zh) |
| KR (1) | KR20180052566A (zh) |
| AU (1) | AU2016287582B2 (zh) |
| CA (1) | CA2991108A1 (zh) |
| HK (1) | HK1254670A1 (zh) |
| MX (1) | MX2017016423A (zh) |
| WO (1) | WO2017004501A1 (zh) |
Family Cites Families (78)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZW19381A1 (en) | 1980-08-12 | 1983-03-09 | Glaxo Group Ltd | Heterocyclic compounds |
| GB9101592D0 (en) | 1991-01-24 | 1991-03-06 | Glaxo Group Ltd | Compositions |
| US5855913A (en) | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
| US20020052310A1 (en) | 1997-09-15 | 2002-05-02 | Massachusetts Institute Of Technology The Penn State Research Foundation | Particles for inhalation having sustained release properties |
| US5985309A (en) | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| US6503480B1 (en) | 1997-05-23 | 2003-01-07 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| USRE37053E1 (en) | 1996-05-24 | 2001-02-13 | Massachusetts Institute Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
| US6652837B1 (en) | 1996-05-24 | 2003-11-25 | Massachusetts Institute Of Technology | Preparation of novel particles for inhalation |
| US6254854B1 (en) | 1996-05-24 | 2001-07-03 | The Penn Research Foundation | Porous particles for deep lung delivery |
| AU718967B2 (en) | 1997-02-05 | 2000-05-04 | Jagotec Ag | Medical aerosol formulations |
| US7799337B2 (en) | 1997-07-21 | 2010-09-21 | Levin Bruce H | Method for directed intranasal administration of a composition |
| US7052678B2 (en) | 1997-09-15 | 2006-05-30 | Massachusetts Institute Of Technology | Particles for inhalation having sustained release properties |
| US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
| WO2000006121A1 (de) | 1998-07-24 | 2000-02-10 | Jago Research Ag | Medizinische aerosolformulierungen |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US6383471B1 (en) | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
| US6395300B1 (en) | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
| US6858199B1 (en) | 2000-06-09 | 2005-02-22 | Advanced Inhalation Research, Inc. | High efficient delivery of a large therapeutic mass aerosol |
| US7252840B1 (en) | 1999-08-25 | 2007-08-07 | Advanced Inhalation Research, Inc. | Use of simple amino acids to form porous particles |
| US20060172017A1 (en) | 1999-11-08 | 2006-08-03 | Capnia, Incorporated | Methods and apparatus for the enhanced delivery of physiologic agents to tissue surfaces |
| ES2303527T3 (es) | 2000-05-10 | 2008-08-16 | Jagotec Ag | Procedimiento de molienda. |
| US6514482B1 (en) | 2000-09-19 | 2003-02-04 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
| US6613308B2 (en) | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
| CA2433335C (en) | 2000-12-29 | 2010-04-20 | Advanced Inhalation Research, Inc. | Particles for inhalation having sustained release properties |
| US6766799B2 (en) | 2001-04-16 | 2004-07-27 | Advanced Inhalation Research, Inc. | Inhalation device |
| US6848197B2 (en) | 2001-04-18 | 2005-02-01 | Advanced Inhalation Research, Inc. | Control of process humidity to produce large, porous particles |
| US6737042B2 (en) | 2001-05-24 | 2004-05-18 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
| US7766013B2 (en) | 2001-06-05 | 2010-08-03 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
| US7090830B2 (en) | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
| US6759029B2 (en) | 2001-05-24 | 2004-07-06 | Alexza Molecular Delivery Corporation | Delivery of rizatriptan and zolmitriptan through an inhalation route |
| US7498019B2 (en) | 2001-05-24 | 2009-03-03 | Alexza Pharmaceuticals, Inc. | Delivery of compounds for the treatment of headache through an inhalation route |
| US7182961B2 (en) | 2001-11-20 | 2007-02-27 | Advanced Inhalation Research, Inc. | Particulate compositions for pulmonary delivery |
| EP1487411B1 (en) | 2002-03-20 | 2019-01-02 | Civitas Therapeutics, Inc. | Inhalable sustained therapeutic formulations |
| AU2002334929C1 (en) | 2002-03-20 | 2006-09-14 | Advanced Inhalation Research, Inc. | Puncturing means for use in an inhalation device |
| US7754242B2 (en) | 2002-03-20 | 2010-07-13 | Alkermes, Inc. | Inhalable sustained therapeutic formulations |
| US7008644B2 (en) | 2002-03-20 | 2006-03-07 | Advanced Inhalation Research, Inc. | Method and apparatus for producing dry particles |
| PT2630954T (pt) | 2002-03-20 | 2017-01-05 | Civitas Therapeutics Inc | Administração pulmonar de levodopa |
| US7582284B2 (en) | 2002-04-17 | 2009-09-01 | Nektar Therapeutics | Particulate materials |
| MXPA04010990A (es) | 2002-05-07 | 2005-02-14 | Nektar Therapeutics | Capsulas para inhaladores de polvo seco y metodo s para elaborarlas y utilizarlas. |
| LT1531794T (lt) | 2002-06-28 | 2017-08-25 | Civitas Therapeutics, Inc. | Inhaliuojamas epinefrinas |
| US6855332B2 (en) | 2002-07-03 | 2005-02-15 | Lyfjathroun Hf. | Absorption promoting agent |
| CN1176649C (zh) | 2002-10-16 | 2004-11-24 | 上海医药工业研究院 | 舒马普坦干粉吸入剂及其制备方法 |
| WO2004073632A2 (en) | 2003-02-19 | 2004-09-02 | Biovail Laboratories Inc. | Rapid absorption selective 5-ht agonist formulations |
| US7954491B2 (en) | 2003-06-13 | 2011-06-07 | Civitas Therapeutics, Inc. | Low dose pharmaceutical powders for inhalations |
| US20050261278A1 (en) | 2004-05-21 | 2005-11-24 | Weiner David M | Selective serotonin receptor inverse agonists as therapeutics for disease |
| JP4922762B2 (ja) | 2004-08-10 | 2012-04-25 | 株式会社新日本科学 | 速効性でかつ高い吸収性を可能とする経鼻投与用組成物 |
| US8268791B2 (en) | 2004-08-25 | 2012-09-18 | Aegis Therapeutics, Llc. | Alkylglycoside compositions for drug administration |
| US20060120962A1 (en) | 2004-10-12 | 2006-06-08 | Rabinowitz Joshua D | Cardiac safe, rapid medication delivery |
| MX2007009635A (es) | 2005-02-10 | 2007-09-25 | Orexo Ab | Nuevas composiciones farmaceuticas utiles en la administracion transmucosa de farmacos. |
| US20090232898A1 (en) | 2005-03-28 | 2009-09-17 | Anders Pettersson | Pharmaceutical Compositions Useful in the Treatment of Migraine |
| FR2891459B1 (fr) | 2005-09-30 | 2007-12-28 | Flamel Technologies Sa | Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant |
| GB0520794D0 (en) | 2005-10-12 | 2005-11-23 | Innovata Biomed Ltd | Inhaler |
| JP2009519972A (ja) * | 2005-12-15 | 2009-05-21 | アキュスフィア， インコーポレイテッド | 粒子ベースの経肺投与または経鼻投与用製薬の製造方法 |
| GB0602897D0 (en) | 2006-02-13 | 2006-03-22 | Jagotec Ag | Improvements In Or Relating To Dry Powder Inhaler Devices |
| GB0613925D0 (en) | 2006-07-13 | 2006-08-23 | Unilever Plc | Improvements relating to nanodispersions |
| US20080066739A1 (en) | 2006-09-20 | 2008-03-20 | Lemahieu Edward | Methods and systems of delivering medication via inhalation |
| US20080078382A1 (en) | 2006-09-20 | 2008-04-03 | Lemahieu Edward | Methods and Systems of Delivering Medication Via Inhalation |
| US20080299048A1 (en) | 2006-12-22 | 2008-12-04 | Alexza Pharmaceuticals, Inc. | Mixed drug aerosol compositions |
| US8337817B2 (en) | 2006-12-26 | 2012-12-25 | Shin Nippon Biomedical Laboratories, Ltd. | Preparation for transnasal application |
| GB2448183A (en) | 2007-04-05 | 2008-10-08 | Optinose As | Nasal powder delivery device |
| WO2008156586A2 (en) | 2007-06-12 | 2008-12-24 | Alkermes, Inc. | Inhalation device for powdered substances |
| US8614255B2 (en) | 2007-08-21 | 2013-12-24 | Civitas Therapeutics, Inc. | Pulmonary pharmaceutical formulations |
| EP2201003A1 (en) | 2007-10-03 | 2010-06-30 | Generics Ýuk¨Limited | Process for the preparation of zolmitriptan, salts and solvates thereof |
| US20090163451A1 (en) | 2007-11-16 | 2009-06-25 | Frank Porreca | Methods for treating visceral pain |
| EP2227085A4 (en) | 2007-12-06 | 2013-10-09 | Berg Pharma Llc | INGREDIBLE COMPOSITIONS WITH INCREASED BIOLOGICAL AVAILABILITY |
| US20110077272A1 (en) | 2008-02-01 | 2011-03-31 | Vectura Limited | Pulmonary formulations of triptans |
| US8899230B2 (en) | 2008-02-15 | 2014-12-02 | Nasologix, Inc. | Aerosol therapy device with high frequency delivery |
| EP2265250A2 (en) | 2008-03-14 | 2010-12-29 | Cephalon, Inc. | Enhanced transmucosal composition and dosage form |
| EP2829265B1 (en) | 2008-04-28 | 2016-08-24 | Zogenix, Inc. | Novel formulations for treatment of migraine |
| US8440631B2 (en) | 2008-12-22 | 2013-05-14 | Aegis Therapeutics, Llc | Compositions for drug administration |
| GB0908129D0 (en) | 2009-05-12 | 2009-06-24 | Innovata Ltd | Composition |
| BR112013011549B1 (pt) | 2010-11-09 | 2022-01-04 | Mannkind Corporation | Composições farmacêuticas compreendendo um agonista do receptor de serotonina e uso das mesmas para tratar sintomas associados com enxaqueca |
| US20130116215A1 (en) | 2011-10-28 | 2013-05-09 | Mireia Coma | Combination therapies for treating neurological disorders |
| WO2013128447A1 (en) | 2012-02-28 | 2013-09-06 | Sipnose Ltd. | Nasal delivery device |
| US8545878B1 (en) * | 2012-11-09 | 2013-10-01 | Civitas Therapeutics, Inc. | Capsules containing high doses of levodopa for pulmonary use |
| CA2891097A1 (en) | 2012-11-16 | 2014-05-22 | Merck Sharp & Dohme Corp. | Process for making agglomerates using acoustic mixing technology |
| KR20180002750A (ko) * | 2015-05-01 | 2018-01-08 | 키비타스 테라퓨틱스, 인코포레이티드. | 폐 전달용 졸미트립탄 분말 |
-
2016
- 2016-07-01 CA CA2991108A patent/CA2991108A1/en not_active Abandoned
- 2016-07-01 AU AU2016287582A patent/AU2016287582B2/en not_active Ceased
- 2016-07-01 MX MX2017016423A patent/MX2017016423A/es unknown
- 2016-07-01 KR KR1020177037801A patent/KR20180052566A/ko unknown
- 2016-07-01 JP JP2017568223A patent/JP2018524346A/ja active Pending
- 2016-07-01 EP EP16818875.3A patent/EP3316865A4/en not_active Withdrawn
- 2016-07-01 US US15/200,335 patent/US10034857B2/en active Active
- 2016-07-01 WO PCT/US2016/040660 patent/WO2017004501A1/en active Application Filing
-
2018
- 2018-10-24 HK HK18113651.3A patent/HK1254670A1/zh unknown
-
2019
- 2019-10-08 US US16/595,933 patent/US20200276160A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3316865A4 (en) | 2019-01-23 |
| JP2018524346A (ja) | 2018-08-30 |
| AU2016287582A1 (en) | 2017-12-21 |
| WO2017004501A1 (en) | 2017-01-05 |
| US20200276160A1 (en) | 2020-09-03 |
| US20170000765A1 (en) | 2017-01-05 |
| US10034857B2 (en) | 2018-07-31 |
| KR20180052566A (ko) | 2018-05-18 |
| CA2991108A1 (en) | 2017-01-05 |
| MX2017016423A (es) | 2018-12-11 |
| EP3316865A1 (en) | 2018-05-09 |
| AU2016287582B2 (en) | 2020-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1245225A1 (zh) | 輸運設施 | |
| GB2520161B (en) | Transport of Powders | |
| GB2524856B (en) | Pulmonary delivery devices | |
| HK1256041A1 (zh) | 乾粉吸入器 | |
| SI3505209T1 (sl) | Inhalator za prah | |
| PL3107548T3 (pl) | Suche formulacje w proszku do inhalacji | |
| ZA201703077B (en) | Dry powder inhaler | |
| GB201618176D0 (en) | Powder removal | |
| HK1251998A1 (zh) | 佐米曲普坦肺部給藥粉 | |
| PL3138601T3 (pl) | Inhalator suchego proszku | |
| GB201411526D0 (en) | Powder | |
| GB201402783D0 (en) | Powder delivery means | |
| PL3179986T3 (pl) | Suche formulacje w proszku do inhalacji | |
| IL249774A0 (en) | Dry powder nebulizer | |
| IL249773A0 (en) | Breaks up lumps of dry powder medicine | |
| GB2553955B (en) | Hydroembedded film-based Composites | |
| GB2524838B (en) | Content delivery architecture | |
| DK3373913T3 (en) | Compacted powder | |
| ZA201702717B (en) | Powder formulation | |
| HK1254670A1 (zh) | 曲普坦粉末用於肺部給藥 | |
| GB201417844D0 (en) | Polydextrose powder | |
| GB201509112D0 (en) | Transport | |
| GB201505784D0 (en) | Silo | |
| GB201412127D0 (en) | The cigarillo | |
| GB201413731D0 (en) | Measuring powder dispenser |